Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 7,421,000 | 6,577,000 | 5,143,000 | 5,548,000 | 5,879,000 |
| Cost of Goods | 1,398,000 | 1,141,000 | 1,064,000 | 969,000 | 1,683,000 |
| Gross Profit | 6,023,000 | 5,436,000 | 4,079,000 | 4,579,000 | 4,196,000 |
| Operating Expenses | 3,372,000 | 3,435,000 | 7,062,000 | 2,177,000 | 3,103,000 |
| Operating Income | 2,651,000 | 2,001,000 | -2,983,000 | 2,402,000 | 1,093,000 |
| Interest Expense | 267,000 | 236,000 | 240,000 | 241,000 | 243,000 |
| Other Income | -570,000 | -940,000 | 250,000 | -158,000 | 1,051,000 |
| Pre-tax Income | 1,814,000 | 825,000 | -2,973,000 | 2,003,000 | 1,901,000 |
| Income Tax | 270,000 | 472,000 | 373,000 | 465,000 | -788,000 |
| Net Income Continuous | 1,544,000 | 353,000 | -3,346,000 | 1,538,000 | 2,689,000 |
| Minority Interests | -7,000 | -7,000 | -7,000 | -13,000 | -7,000 |
| Net Income | $1,551,000 | $360,000 | $-3,339,000 | $1,551,000 | $2,696,000 |
| EPS Basic Total Ops | 1.24 | 0.29 | -2.66 | 1.23 | 2.13 |
| EPS Basic Continuous Ops | 1.24 | 0.28 | -2.67 | 1.22 | 2.13 |
| EPS Diluted Total Ops | 1.25 | 0.29 | -2.66 | 1.22 | 2.13 |
| EPS Diluted Continuous Ops | 1.25 | 0.28 | -2.67 | 1.21 | 2.12 |
| EBITDA(a) | $3,078,000 | $2,356,000 | $-2,634,000 | $2,751,000 | $1,443,000 |